8-K
Current Report
Tempest Therapeutics, Inc. Filed Acc 0001193125-22-314745
Material agreement · New debt or obligation
- Item 1.01 Entry into a material definitive agreement
- Item 2.03 Creation of a direct financial obligation
From the SEC's structured data for this filing
Loading d411465d8k.htm…